Correlation of PIM kinases with tumor immune microenvironment and clinical presentation of metastatic hormone-sensitive prostate cancer.

被引：0
作者：
Recio-Boiles, Alejandro
Clements, Amber N.
Deshmukh, Sachin Kumar
Bertolo, Aaron
Estrada-Mendizabal, Ricardo J.
Saboda, Kathylynn
Wu, Sharon
Xiu, Joanne
Radovich, Milan
Sutterby, Kai
Chauhan, Shailender S.
McKay, Rana R.
Nabhan, Chadi
Warfel, Noel A.
机构：
[1] Univ Arizona, Canc Ctr, Tucson, AZ USA
[2] Caris Life Sci, Phoenix, AZ USA
[3] Tecnol Monterrey, Escuela Med & Ciencias Salud, Monterrey, Mexico
[4] Univ Calif San Diego, La Jolla, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 4_SUPPL期
关键词：
D O I：
10.1200/JCO.2024.42.4_suppl.211
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
211
引用
收藏
页码：211 / 211
页数：1
相关论文
共 50 条
[41]   Chemotherapy, not androgen receptor-targeted therapy should be used upfront for metastatic hormone-sensitive prostate cancer. PRO: docetaxel chemotherapy should be the default consideration in metastatic hormone-sensitive prostate cancer [J].
Kwan, Edmond M. ;
Azad, Arun A. .
CURRENT OPINION IN UROLOGY, 2020, 30 (04) :617-619
[42]   Triplet Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer [J].
Hindie, Elif .
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (22) :3873-3875
[43]   Re: Darolutamide and Survival in Metastatic, Hormone-sensitive Prostate Cancer [J].
Olivier, Timothee ;
Tsantoulis, Petros ;
Prasad, Vinay .
EUROPEAN UROLOGY, 2023, 83 (06) :584-585
[44]   Optimal Pharmacotherapeutic Management of Hormone-Sensitive Metastatic Prostate Cancer [J].
Ajjai Alva ;
Maha Hussain .
Drugs, 2013, 73 :1517-1524
[45]   Metastatic hormone-sensitive prostate cancer: How should it be treated? [J].
Lopez-Campos, Fernando ;
Gonzalez-San Segundo, Carmen ;
Conde-Moreno, Antonio Jose ;
Counago, Felipe .
WORLD JOURNAL OF CLINICAL ONCOLOGY, 2021, 12 (02) :43-49
[46]   Re: Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer [J].
Mathieu, Romain ;
Shariat, Shahrokh F. .
EUROPEAN UROLOGY, 2016, 69 (04) :755-756
[47]   Re: Darolutamide and Survival in Metastatic, Hormone-sensitive Prostate Cancer [J].
Chen, Kenneth ;
McVey, Aoife ;
Kasivisvanathan, Veeru ;
Jenjitranant, Pocharapong ;
Azad, Arun ;
Murphy, Declan G. .
EUROPEAN UROLOGY, 2022, 82 (01) :146-147
[48]   Estrogen receptor β and TMPRSS2-ERG expression association with clinical outcomes in metastatic hormone-sensitive prostate cancer. [J].
Aversa, Caterina ;
Enez, Natalia Jim . ;
Marin, Mercedes ;
Ferrer-Mileo, Laura ;
Reig, Oscar ;
Rodriguez-Carunchio, Leonardo ;
Font, Albert ;
Rodriguez-Vida, Alejo ;
Domenech-Santasusana, Montserrat ;
Figols, Mariona ;
Duran, Miguel Angel Climent ;
Costa, Sara Cros ;
Chirivella, Isabel ;
Rivera, Daniel Herrero ;
Gonzalez-Billalabeitia, Enrique ;
Enez-Peralta, Daniel Jim ;
Carles, Joan ;
Suarez, Cristina ;
Prat, Aleix ;
Mellado, Begona .
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
[49]   Optimal Pharmacotherapeutic Management of Hormone-Sensitive Metastatic Prostate Cancer [J].
Alva, Ajjai ;
Hussain, Maha .
DRUGS, 2013, 73 (14) :1517-1524
[50]   Metastatic hormone-sensitive prostate cancer: local treatment strategies [J].
Montorsi, Francesco ;
Martini, Alberto ;
Gandaglia, Giorgio ;
Fossati, Nicola ;
Stabile, Armando ;
Deho, Federico ;
Salonia, Andrea ;
Briganti, Alberto .
WORLD JOURNAL OF UROLOGY, 2022, 40 (03) :881-882
12345